CODIAK BIOSCIENCES INC (CDAK) Earnings History & Surprises

NASDAQ:CDAK • US1920101060

0.057 USD
-0.07 (-55.98%)
At close: Apr 4, 2023
0.0399 USD
-0.02 (-30%)
After Hours: 4/4/2023, 8:04:03 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

Past quarterly earnings results for CODIAK BIOSCIENCES INC (CDAK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).

Earnings Snapshot

Next Earnings Date

Upcoming
Release DateMay 3, 2023
PeriodQ4 / 2022
EPS Estimate-$0.35
Revenue Estimate691.897K

Last Reported

Most Recent
Release DateMar 15, 2023
PeriodQ3 / 2022
EPS Reported-$0.59
EPS Surprise 29.46%
Revenue Surprise -12.92%

Beat Rate

Last 8 Quarters
0%
EPS and Revenuebeats vs estimates

Quarterly Earnings Results

EPS & Revenue History (USD)

Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.

QuarterEPSEPS EstEPS SurpriseEPS Q2QRevenueRevenue EstRevenue SurpriseRevenue Q2Q
Q3 2022 -0.59 -0.84 29.46% 39.18% 522K 599.423K -12.92% -54.88%
Q2 2022 -0.30 -0.85 64.85% 69.70% 13.145M 554.543K 2,270.42% 1,376.97%
Q1 2022 -0.36 -0.91 60.49% 29.41% 12.704M 4.284M 196.55% -3.68%
Q4 2021 -0.74 -0.96 23.09% 35.09% 7.697M 1.545M 398.19% 369.33%
Q3 2021 -0.97 -0.96 -0.63% 92.44% 1.157M 1.464M -20.97% 21.79%
Q2 2021 -0.99 -1.07 7.27% - 890K 1.377M -35.37% 177.26%
Q1 2021 -0.51 -1.12 54.27% - 13.19M 985.32K 1,238.65% -
Q4 2020 -1.14 -1.57 27.27% - 1.64M 534.48K 206.84% -
Q3 2020 -12.83 -5.61 -128.84% - 950K 124.95K 660.30% -
Q2 2020 - - 321K - -

Notes

  • EPS and Revenue values are non-GAAP when available, otherwise GAAP.
  • Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
  • Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
  • Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.

Earnings Q2Q Performance Trends

EPS Historical Q2Q growth and Acceleration

CDAK EPS Q2Q GrowthCDAK EPS Q2Q GrowthEPS Q2Q Growth Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 0 20 40 60 80

Revenue Historical Q2Q growth and Acceleration

CDAK Revenue Q2Q GrowthCDAK Revenue Q2Q GrowthRevenue Q2Q Growth Q2/21 Q3/21 Q4/21 Q1/22 Q2/22 Q3/22 Q4/22 Q1/23 Q2/23 Q3/23 Q4/23 Q1/24 Q2/24 Q3/24 Q4/24 0 500 1K

Surprise distribution (Last 4 Quarters)

EPS beat statistics

EPS beat (4)
4
Average EPS beat (4)
44.47%
Max EPS beat (4)
64.85%
Min EPS beat (4)
23.09%

Revenue beat statistics

Revenue beat (4)
3
Average Revenue beat (4)
713.06%
Max Revenue beat (4)
2,270.42%
Min Revenue beat (4)
-12.92%

Analysis

In the last 4 quarters, CDAK has consistently beaten EPS estimates in all releases
CDAK has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, CDAK has beaten the EPS estimates by 44.5% on average.
In the last 4 quarters, CDAK has beaten the revenue estimates by 713.1% on average.

Related analysis

CDAK Overview CDAK Technical Analysis Report CDAK Fundamental Analysis Report CDAK Forecast & Price Target
 → Find peers who consistently beat earnings by at least 10% in the last 4 quarters

CODIAK BIOSCIENCES INC / CDAK Earnings FAQ

When did CODIAK BIOSCIENCES INC (CDAK) report earnings last quarter?

CODIAK BIOSCIENCES INC (CDAK) last reported earnings on 3/15/2023.


Did CDAK stock beat earnings estimates in the most recent quarter?

CODIAK BIOSCIENCES INC (CDAK) beat EPS estimates and missed revenue estimates in the most recent quarter.


Can you provide information on how often CODIAK BIOSCIENCES INC beats earnings estimates?

In the last 4 quarters, CODIAK BIOSCIENCES INC (CDAK) has beaten EPS estimates in 4 out of 4 releases.